← Back
$MPLT All transactions

MapLight Therapeutics, Inc.

F

$ Value

$396K

Shares

22,050

Price

$18

Filed

Jan 29

Insider

Name

GILLIS JONATHAN

Title

CAAO and PAO

CIK

0001709954

Roles

Officer

Transaction Details

Transaction Date

2026-01-27

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

248,503

Footnotes

Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock unit awards. The securities of the Issuer retained by the Reporting Person remain subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's initial public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 180 days following the date of the final prospectus relating to the initial public offering, which was October 26, 2025.

Filing Info

Accession No.

0001709954-26-000002

Form Type

4

Issuer CIK

0001770069

GILLIS JONATHAN's History

Date Ticker Type Value
2026-04-15 MPLT $96K
2026-02-05 MPLT A $0
2026-02-05 MPLT A $0
2026-01-27 MPLT F $396K
2025-10-27 MPLT A $0
2025-10-27 MPLT A $0

Other Insiders at MPLT (90d)

Insider Bought Sold Last
Pavlov George $441K 2026-02-20
Garnett Timothy John $253K 2026-02-10
Kroeger Christopher A.
Chief Executive Officer
$521K 2026-04-16
GILLIS JONATHAN
CAAO and PAO
$96K 2026-04-15
Lillie James Woodruff
Chief Scientific Officer
$123K 2026-04-16
Hanson Kristopher
General Counsel
$49K 2026-04-16
Malenka Robert C. $1.6M 2026-04-15
Foff Erin Pennock
Chief Medical Officer
$87K 2026-04-16
Kreitzer Anatol
Chief Discovery Officer
$88K 2026-04-15
Setia Vishwas
Chief Financial Officer
$79K 2026-04-16